Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,154.00
Bid: 12,152.00
Ask: 12,156.00
Change: -16.00 (-0.13%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: AstraZeneca, Boxing Day, Britain's economy

Sun, 27th Dec 2020 12:39

(Sharecast News) - The chief executive of AstraZeneca has raised hopes its vaccine with Oxford is more effective than first thought amid the rapid spread of the new UK virus strain across the globe. Pascal Soriot said he believed researchers had found the "winning formula" using two doses and promised to publish the results as reports suggested the UK regulator could approve the jab within days. - Sunday Telegraph

Footfall at the Boxing Day sales was down by more than half on last year as non-essential retail remained closed in much of the country under tightened coronavirus restrictions. While queues were seen outside shops in areas under tiers 2 and 3, high streets in the 43% of England that is under tier 4 were empty. The retail intelligence agency Springboard said Boxing Day footfall in the UK up to 10am was down 57% compared with last year. - Guardian

Britain's economy will outperform European rivals such as France over the next 15 years, according to morale-boosting forecasts published in the wake of the Government's Brexit trade deal with Brussels. A new ranking shows the UK remaining the world's 5th biggest economy next year. From 2025 it slips one place, but still performs better than many peer western economies. The UK's economy will be 23pc larger than that of France by 2035, the Centre for Economics and Business Research (CEBR) predicts. - Sunday Telegraph

The car industry is in a race against time to build giant battery gigafactories in the UK to ensure its survival and avoid damaging tariffs from the Brexit trade deal. Details of the EU deal revealed that Britain has a six-year window to build its supply of electric vehicle parts - either domestically or from the Continent - if it wants to continue selling them tariff-free to Europe. - Sunday Times

Bankers are gearing up for a surge of flotations on the London Stock Exchange next year as companies that delayed listing their shares due to the pandemic press ahead with plans to tap public markets. Dealmakers said they expect a boom in initial public offerings (IPOs) driven by pent up demand after pandemic disruption effectively halted new listings for much of 2020. Advisers predicted increased investor appetite for tech and healthcare firms that have done well in the crisis. - Sunday Telegraph

More than three-quarters of MPs are expected to dial in remotely to a debate that will consider the government's Brexit deal on Wednesday. The majority of MPs are preparing to participate online after the Commons speaker urged them to stay at home and made it clear those present in person will not be given priority to speak. Both the Commons and the Lords will sit for a single day on December 30 to pass the Future Relationship Bill implementing the government's free trade deal with the EU. - Sunday Times

Industry figures are calling on EU leaders to urgently agree a Brexit "adjustment period" after negotiators left them with just three working days to prepare for the end of the Brexit transition period. While big business including manufacturers and supermarkets have made Brexit preparations costing hundreds of millions of pounds, they say there is not enough time over Christmas to implement the newly agreed trading regime. - Guardian

The Bank of England could pull the trigger on negative interest rates if strict coronavirus restrictions are extended well into the new year, leading economists have warned. Interest rates are at record lows of 0.1%, leaving rate-setters with little room to move and raising the prospect of negative rates in the UK for the first time. - Sunday Times

City veteran Keith Skeoch has been appointed by the Treasury to lead a review of banking regulations in what could be the biggest overhaul of the sector since the fallout of the financial crisis a decade ago. The former chief executive of Standard Life Aberdeen will revisit the stringent rules put in place to rein in banks after several were bailed out by the Government in 2008, including Royal Bank of Scotland, Lloyds TSB and HBOS. - Financial Mail on Sunday
More News
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.